Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SANUWAVE Health (SNWV) Non-Current Assets (2023 - 2025)

Historic Non-Current Assets for SANUWAVE Health (SNWV) over the last 10 years, with Q3 2025 value amounting to $13.0 million.

  • SANUWAVE Health's Non-Current Assets rose 859.3% to $13.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.0 million, marking a year-over-year increase of 859.3%. This contributed to the annual value of $11.7 million for FY2024, which is 720.39% down from last year.
  • Per SANUWAVE Health's latest filing, its Non-Current Assets stood at $13.0 million for Q3 2025, which was up 859.3% from $12.9 million recorded in Q2 2025.
  • In the past 5 years, SANUWAVE Health's Non-Current Assets ranged from a high of $13.1 million in Q2 2023 and a low of $11.7 million during Q4 2024
  • For the 3-year period, SANUWAVE Health's Non-Current Assets averaged around $12.5 million, with its median value being $12.6 million (2023).
  • Per our database at Business Quant, SANUWAVE Health's Non-Current Assets plummeted by 778.5% in 2024 and then skyrocketed by 859.3% in 2025.
  • Quarter analysis of 3 years shows SANUWAVE Health's Non-Current Assets stood at $12.6 million in 2023, then decreased by 7.2% to $11.7 million in 2024, then rose by 10.61% to $13.0 million in 2025.
  • Its Non-Current Assets stands at $13.0 million for Q3 2025, versus $12.9 million for Q2 2025 and $12.0 million for Q1 2025.